USP15 negatively regulates Nrf2 through deubiquitination of Keap1.

[1]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[2]  J. Baselga,et al.  USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma , 2012, Nature Medicine.

[3]  Leonardo Morsut,et al.  USP15 is a deubiquitylating enzyme for receptor-activated SMADs , 2011, Nature Cell Biology.

[4]  Ximing J. Yang,et al.  An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. , 2011, Cancer cell.

[5]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[6]  Donna D. Zhang,et al.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism , 2011, Proceedings of the National Academy of Sciences.

[7]  Donna D. Zhang,et al.  Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. , 2010, Antioxidants & redox signaling.

[8]  M. McMahon,et al.  Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. , 2010, Antioxidants & redox signaling.

[9]  N. Chen,et al.  High levels of Nrf2 determine chemoresistance in type II endometrial cancer. , 2010, Cancer research.

[10]  Jia Wei,et al.  CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer. , 2010, Anticancer research.

[11]  E. White,et al.  A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.

[12]  Yi-feng Lin,et al.  The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy , 2010, Diabetes.

[13]  M. Kudo,et al.  USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis. , 2009, Biochemical and biophysical research communications.

[14]  J. Chapiro,et al.  COP9 Signalosome Interacts ATP-dependently with p97/Valosin-containing Protein (VCP) and Controls the Ubiquitination Status of Proteins Bound to p97/VCP* , 2009, The Journal of Biological Chemistry.

[15]  K. Hofmann,et al.  F-box-directed CRL complex assembly and regulation by the CSN and CAND1. , 2009, Molecular cell.

[16]  M. McMahon,et al.  Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. , 2009, Carcinogenesis.

[17]  W. Schwenk,et al.  The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15. , 2009, Journal of molecular biology.

[18]  Donna D. Zhang,et al.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.

[19]  P. Howley,et al.  The Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability , 2009, Journal of Virology.

[20]  Keith D Wilkinson,et al.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. , 2009, Annual review of biochemistry.

[21]  M. McMahon,et al.  NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. , 2009, Trends in biochemical sciences.

[22]  Donna D. Zhang,et al.  Acetylation of Nrf2 by p300/CBP Augments Promoter-Specific DNA Binding of Nrf2 during the Antioxidant Response , 2009, Molecular and Cellular Biology.

[23]  P. Wong,et al.  Dual roles of Nrf2 in cancer. , 2008, Pharmacological research.

[24]  S. Hirohashi,et al.  Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. , 2008, Gastroenterology.

[25]  Donna D. Zhang,et al.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. , 2008, Carcinogenesis.

[26]  S. Hirohashi,et al.  Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. , 2008, Cancer research.

[27]  Donna D. Zhang,et al.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. , 2007, Toxicology and applied pharmacology.

[28]  J. Boettcher,et al.  Ubiquitin-dependent proteolysis of the microtubule end-binding protein 1, EB1, is controlled by the COP9 signalosome: possible consequences for microtubule filament stability. , 2007, Journal of molecular biology.

[29]  M. Naumann,et al.  CSN controls NF‐κB by deubiquitinylation of IκBα , 2007 .

[30]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[31]  J. Herman,et al.  Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.

[32]  C. Chien,et al.  Protection of cullin-RING E3 ligases by CSN-UBP12. , 2006, Trends in cell biology.

[33]  G. Winberg,et al.  Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines , 2006, Molecular carcinogenesis.

[34]  Tsutomu Ohta,et al.  Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.

[35]  A. Kong,et al.  Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. , 2006, Antioxidants & redox signaling.

[36]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[37]  M. Lieberman,et al.  Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway* , 2005, Journal of Biological Chemistry.

[38]  P. Kloetzel,et al.  The Zinc Finger of the CSN-Associated Deubiquitinating Enzyme USP15 Is Essential to Rescue the E3 Ligase Rbx1 , 2005, Current Biology.

[39]  T. Toda,et al.  CSN facilitates Cullin–RING ubiquitin ligase function by counteracting autocatalytic adapter instability , 2005, Nature Cell Biology.

[40]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[41]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[42]  Ken Itoh,et al.  Redox-regulated Turnover of Nrf2 Is Determined by at Least Two Separate Protein Domains, the Redox-sensitive Neh2 Degron and the Redox-insensitive Neh6 Degron* , 2004, Journal of Biological Chemistry.

[43]  J. D. Engel,et al.  Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Ploegh,et al.  Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[46]  R. Deshaies,et al.  COP9 Signalosome A Multifunctional Regulator of SCF and Other Cullin-Based Ubiquitin Ligases , 2003, Cell.

[47]  C. Chung,et al.  Deubiquitinating enzymes as cellular regulators. , 2003, Journal of biochemistry.

[48]  M. Naumann,et al.  Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. , 2003, Molecular cell.

[49]  D. Harrison,et al.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. , 1999, The Biochemical journal.

[50]  A. Ciechanover,et al.  A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. , 1988, The Journal of biological chemistry.

[51]  Masayuki Yamamoto,et al.  Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. , 2006, Advances in enzyme regulation.

[52]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.